Endoscope Reprocessing Chemicals Market Size to Hit USD 2.06 Billion by 2035

Endoscope Reprocessing Chemicals Market Size in 2026

The global endoscope reprocessing chemicals market size was valued at USD 1.09 billion in 2025 and is expected to grow from USD 1.16 billion in 2026 to approximately USD 2.06 billion by 2035, expanding at a CAGR of 6.55% from 2026 to 2035.

This market growth is primarily driven by the rising need for infection control, increasing adoption of minimally invasive procedures, and stringent regulatory standards ensuring patient safety across healthcare facilities.

Read Also: Particle Therapy Market

Market Overview

Endoscope reprocessing chemicals include specialized detergents, disinfectants, and sterilization agents designed to clean and disinfect flexible and rigid endoscopes after use. These devices are widely utilized in gastrointestinal, pulmonary, urological, and surgical procedures.

Due to their complex design—with narrow lumens and multiple channels—endoscopes are particularly challenging to clean. Proper reprocessing is essential to eliminate microorganisms and prevent cross-contamination, making chemical solutions a critical component of infection control protocols.

The market is witnessing consistent growth due to:

• Increasing global surgical volumes
• Rising awareness of hospital-acquired infections (HAIs)
• Strict regulatory compliance requirements
• Expansion of outpatient and ambulatory care centers

Impact of Artificial Intelligence on the Market

Artificial Intelligence (AI) is significantly transforming endoscope reprocessing by improving efficiency, safety, and compliance.

Key AI-driven advancements include:

• Automated monitoring of chemical concentration, temperature, and contact time
• Real-time detection of reprocessing irregularities through smart sensors
• Predictive inventory management to avoid shortages and reduce waste
• Process optimization to ensure consistent high-level disinfection

AI integration reduces human error, enhances workflow efficiency, and ensures adherence to infection control standards in hospitals and diagnostic centers.

Key Market Trends

Growing Adoption of Automated Endoscope Reprocessors (AERs)

Healthcare facilities are increasingly adopting automated systems that require specialized chemical formulations for consistent and reliable disinfection.

Shift Toward Safer and Eco-Friendly Chemicals

Manufacturers are focusing on low-toxicity, environmentally friendly disinfectants that ensure safety for both patients and healthcare workers.

Rising Prevalence of HAIs

The growing incidence of hospital-acquired infections is driving demand for high-level disinfectants such as peracetic acid and hydrogen peroxide-based solutions.

Expansion of Ambulatory Care Centers

Outpatient facilities are increasing demand for cost-effective and easy-to-use reprocessing chemicals to maintain high throughput and sterilization standards.

Market Scope

• Market Size in 2025: USD 1.09 Billion
• Market Size in 2026: USD 1.16 Billion
• Market Size by 2035: USD 2.06 Billion
• CAGR (2026–2035): 6.55%
• Base Year: 2025
• Forecast Period: 2026–2035
• Dominant Region: North America
• Fastest Growing Region: Asia Pacific

Segmental Insights

By Chemistry Type

High-Level Disinfectants Lead the Market

High-level disinfectants dominated the market in 2025 due to their ability to eliminate a broad spectrum of microorganisms, including bacteria, viruses, fungi, and spores. These chemicals are essential for semi-critical devices like endoscopes, which come into contact with mucous membranes.

Enzymatic Cleaners Growing Rapidly

Enzymatic cleaners are expected to grow significantly due to their effectiveness in breaking down organic matter such as blood, tissue, and biofilms. Proper pre-cleaning enhances the effectiveness of disinfection processes.

By Disinfectant Type

Peracetic Acid Dominance

Peracetic acid held a major share in 2025 due to:

• Broad-sphttps://www.pharma-geek.com/particle-therapy-market-2/ectrum antimicrobial activity
• Rapid action and effectiveness at low concentrations
• Strong performance in the presence of organic matter

Ortho-Phthalaldehyde (OPA) Growth

OPA is expected to grow rapidly due to:

• Better material compatibility
• Lower odor and toxicity
• Ease of use and shorter exposure times

By Endoscope Type

GI Endoscopes Lead the Market

Gastrointestinal (GI) endoscopes dominated the market due to the high volume of procedures such as colonoscopies and endoscopies. Increased awareness of early disease detection has significantly boosted demand.

Urology Endoscopes Expansion

The urology segment is expected to grow due to rising cases of:

• Kidney stones
• Bladder cancer
• Urinary tract infections

By Reprocessing Platform

Automated Endoscope Reprocessors (AERs) Dominate

AER systems led the market due to their ability to:

• Standardize disinfection processes
• Reduce human error
• Improve turnaround time
• Ensure compliance with infection control guidelines

Manual Reprocessing Growth

Manual reprocessing remains relevant, especially in cost-sensitive and resource-limited settings, due to lower capital investment requirements.

Regional Analysis

North America

North America dominated the market in 2025 due to:

• Advanced healthcare infrastructure
• High procedure volumes
• Strict infection control regulations

The presence of regulatory bodies like the FDA and CDC ensures compliance with stringent sterilization standards, driving demand for high-quality reprocessing chemicals.

Asia Pacific

Asia Pacific is expected to grow at the fastest CAGR due to:

• Expanding healthcare infrastructure
• Rising awareness of infection control
• Increasing minimally invasive procedures
• Government initiatives supporting healthcare development

Countries like India, China, and Japan are witnessing rapid growth in diagnostic and surgical procedures.

Europe

Europe is experiencing steady growth driven by:

• Strict regulatory compliance
• Aging population
• Rising prevalence of chronic diseases
• Strong focus on patient safety

Competitive Landscape

Key companies operating in the market include:

• Advanced Sterilization Products (ASP)
• STERIS
• Getinge
• Ecolab
• Olympus Corporation
• Cantel (STERIS)
• Metrex
• Schülke & Mayr
• Paul Hartmann
• Johnson & Johnson

These companies focus on product innovation, regulatory compliance, and expanding their global presence.

Recent Developments

• In May 2025, Olympus Corporation introduced the ScopeLocker Air drying cabinet to enhance endoscope drying efficiency and infection control workflows.
• In March 2025, Nanosonics received FDA De Novo clearance for its CORIS system, an automated solution designed to improve cleaning of internal channels of flexible endoscopes.

Conclusion

The endoscope reprocessing chemicals market is set for sustained growth, driven by increasing healthcare awareness, rising surgical volumes, and stringent infection control requirements. With continuous advancements in chemical formulations and the integration of AI-powered automation, the market is evolving toward safer, more efficient, and environmentally sustainable solutions.

As healthcare systems worldwide prioritize patient safety and operational efficiency, demand for advanced reprocessing chemicals is expected to rise significantly, creating strong opportunities for market players in the coming years.

Get Sample Copy: https://www.precedenceresearch.com/sample/8053

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com